FIELD: chemistry.
SUBSTANCE: present invention relates to novel compounds of general formulae II, III, IV and V, where values of radicals are given in description, or pharmaceutically acceptable salts thereof, which can be used as PDK1 inhibitors.
EFFECT: present invention also relates to pharmaceutical compositions based thereon and to methods of treating cancer, mediated by protein kinase PDK1.
32 cl, 2 tbl, 445 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | 2009 |
|
RU2514937C2 |
| PYRROLOPYRIDINONE DERIVATIVES AS TTX-S BLOCKERS | 2013 |
|
RU2646754C2 |
| PYRIDONE AND AZA-PYRIDONE COMPOUNDS AND METHODS OF USE | 2011 |
|
RU2617405C2 |
| HETEROCYCLIC COMPOUNDS AND METHODS OF APPLICATION | 2009 |
|
RU2525116C2 |
| THIOHYDANTOIN DERIVATIVES USEFUL AS ANDROGEN RECEPTOR ANTAGONISTS | 2012 |
|
RU2598854C2 |
| REGULATOR BASED ON NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2020 |
|
RU2829553C2 |
| ANTI-PROLIFERATIVE COMPOUNDS AND THEIR APPLICATIONS | 2019 |
|
RU2811969C2 |
| MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
| SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
| BROMDOMAIN INHIBITORS | 2012 |
|
RU2647592C2 |
